Shingrix, given in two doses 2 to 6 months apart, is for adults aged 50 years and older. It was shown to achieve ≥90% efficacy in clinical trials.International Approvals http://ift.tt/2yiUUWf
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου